- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Citryll B.V.
BioCentury | Dec 13, 2024
Finance
Techbio VC Dimension upsizes for $500M second fund; PE firm takes stake in Andera
In BioCentury’s Venture Report: Fundings for Citryll, Angitia, Tasca, Veradermics and more
BioCentury | Feb 14, 2024
Management Tracks
New CEOs for Enable, StromaCare
Plus: Philippakis joins GV as general partner, and updates from Verily, Meliora, Citryll and Silver Creek
BioCentury | Aug 29, 2023
Management Tracks
Crossover-backed Arbor names Tamboli CFO
Plus: Atkinson named chief technical operations officer at Vertex, and updates from Confo, Flagship, Citryll and more
BioCentury | Jan 8, 2021
Finance
More strategics pile into Dutch early-stage investor BGV’s largest-ever fund
€140 million fourth fund gains new strategic backers Lilly, Novo Ventures
BioCentury | Jul 22, 2020
Management Tracks
Meeker expands role at Rhythm; plus Biogen, Kronos, Citryll, Akcea, ImmunoGen, Circle, Antares and more
BioCentury | Jul 3, 2019
Financial News
July 3 Financial Quick Takes: Mega-round for China’s Lepu; plus Citryll, Jibeier and Calliditas
BioCentury | May 12, 2016
Targets & Mechanisms
Another shot at the flu
Targeting caspases may prevent flu-associated death in the elderly
BioCentury | Jul 9, 2015
Product R&D
Downstream without a NET
How newco Citryll B.V.'s antibody could treat autoimmune diseases
Items per page:
1 - 8 of 8